Toward next-generation cancer immunotherapy: 10th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23–25, 2012
- 465 Downloads
With 620 international participants, more than 70 speakers and 216 abstracts, the 2012 Annual Meeting of the Association for Cancer Immunotherapy (CIMT) celebrated its 10th anniversary as the premier European meeting dedicated to research and development of cancer immunotherapy. The latest advances of the field were discussed in sessions on cellular therapies, immunomonitoring, new targets and leads, therapeutic vaccination, tumor biology and immune interaction. Here, we summarize the highlights of the meeting which were representative of the newest advances and trends in the field of cancer immunotherapy.
The 10th anniversary meeting especially highlighted the path to personalized cancer therapy. Translating promising research concepts into the clinic still faces a myriad of challenges. The complex application of novel technologies, biomarkers and immune monitoring, the demands of GMP manufacturing as well as regulatory questions continue to test...
KeywordsCirculate Tumor Cell Cancer Immunotherapy Chimeric Antigen Receptor BRAF Inhibitor Adoptive Cell Therapy
Conflict of interest
The authors declare that they have no conflict of interest. Cedrik Britten has been co-organizer of the meeting.